These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1603808)

  • 21. The folding and dimerization of HIV-1 protease: evidence for a stable monomer from simulations.
    Levy Y; Caflisch A; Onuchic JN; Wolynes PG
    J Mol Biol; 2004 Jun; 340(1):67-79. PubMed ID: 15184023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular dynamics study of the structural stability of HIV-1 protease under physiological conditions: the role of Na+ ions in stabilizing the active site.
    Kovalskyy D; Dubyna V; Mark AE; Kornelyuk A
    Proteins; 2005 Feb; 58(2):450-8. PubMed ID: 15562519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flap opening mechanism of HIV-1 protease.
    Tóth G; Borics A
    J Mol Graph Model; 2006 May; 24(6):465-74. PubMed ID: 16188477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation of protein/ligand crystal structure using QM/MM calculations: case of HIV-1 protease/metallacarborane complex.
    Fanfrlík J; Brynda J; Rezác J; Hobza P; Lepsík M
    J Phys Chem B; 2008 Nov; 112(47):15094-102. PubMed ID: 18975888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S; Shah K
    In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease.
    Zhu Z; Schuster DI; Tuckerman ME
    Biochemistry; 2003 Feb; 42(5):1326-33. PubMed ID: 12564936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.
    Thorsteinsdottir HB; Schwede T; Zoete V; Meuwly M
    Proteins; 2006 Nov; 65(2):407-23. PubMed ID: 16941468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular dynamics simulations of peptides and proteins with a continuum electrostatic model based on screened Coulomb potentials.
    Hassan SA; Mehler EL; Zhang D; Weinstein H
    Proteins; 2003 Apr; 51(1):109-25. PubMed ID: 12596268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.
    Swairjo MA; Towler EM; Debouck C; Abdel-Meguid SS
    Biochemistry; 1998 Aug; 37(31):10928-36. PubMed ID: 9692985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dramatic differences in the motions of the mouth of open and closed cytochrome P450BM-3 by molecular dynamics simulations.
    Paulsen MD; Ornstein RL
    Proteins; 1995 Mar; 21(3):237-43. PubMed ID: 7784427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational flexibility in the flap domains of ligand-free HIV protease.
    Heaslet H; Rosenfeld R; Giffin M; Lin YC; Tam K; Torbett BE; Elder JH; McRee DE; Stout CD
    Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):866-75. PubMed ID: 17642513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening of new HIV inhibitors based on the database of traditional Chinese medicine].
    Gao WN; Li Y; Zhang R; Gao H; Xu WR; Li AX; Du QS; Zhang X; Wei DQ
    Yao Xue Xue Bao; 2006 Mar; 41(3):241-6. PubMed ID: 16758996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations.
    Hünenberger PH; Mark AE; van Gunsteren WF
    J Mol Biol; 1995 Sep; 252(4):492-503. PubMed ID: 7563068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 175-psec molecular dynamics simulation of camphor-bound cytochrome P-450cam.
    Paulsen MD; Ornstein RL
    Proteins; 1991; 11(3):184-204. PubMed ID: 1749772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors.
    Li D; Liu MS; Ji B; Hwang K; Huang Y
    J Chem Phys; 2009 Jun; 130(21):215102. PubMed ID: 19508101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solvation influences flap collapse in HIV-1 protease.
    Meagher KL; Carlson HA
    Proteins; 2005 Jan; 58(1):119-25. PubMed ID: 15521062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closing of the flaps of HIV-1 protease induced by substrate binding: a model of a flap closing mechanism in retroviral aspartic proteases.
    Tóth G; Borics A
    Biochemistry; 2006 May; 45(21):6606-14. PubMed ID: 16716071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of homology modeling of HIV protease.
    Weber IT
    Proteins; 1990; 7(2):172-84. PubMed ID: 2158092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dynamics simulation of equine infectious anemia virus Tat protein in water and in 40% trifluoroethanol.
    Sticht H; Willbold D; Rösch P
    J Biomol Struct Dyn; 1994 Aug; 12(1):019-36. PubMed ID: 7848558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease.
    Specker E; Böttcher J; Brass S; Heine A; Lilie H; Schoop A; Müller G; Griebenow N; Klebe G
    ChemMedChem; 2006 Jan; 1(1):106-17. PubMed ID: 16892342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.